Research graph
References from Coupling photodynamic hypoxia amplification with a self-reporting chemiluminescent prodrug for adaptive precision therapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Nanomedicine strategies in conquering and utilizing the cancer hypoxia environment
10.1021/acsnano.3c07763 · 2023 · External reference
Hypoxia as a medicine
10.1126/scitranslmed.adr4049 · 2025 · External reference
Tumour Hypoxia in driving genomic instability and tumour evolution
2025 · External reference
Conquering the hypoxia limitation for photodynamic therapy
10.1002/adma.202103978 · 2021 · External reference
Targeting Hypoxia in cancer therapy
10.1038/nrc3064 · 2011 · External reference
Research progress on tumor hypoxia-associative nanomedicine
10.1016/j.jconrel.2022.09.003 · 2022 · External reference
Tumor microenvironment-responsive PROTAC prodrugs: a pioneering strategy for precision cancer therapy
2026 · External reference
The rise and promise of macrocyclic hosts in biomedicine
10.1021/acscentsci.5c00891 · 2025 · External reference
Azobenzene-based linker strategy for selective activation of antibody-drug conjugates
10.1002/anie.202310318 · 2024 · External reference
Application of hypoxia-activated prodrugs in tumor therapy: design strategies and perspectives
10.1021/acs.jmedchem.5c02094 · 2025 · External reference
Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs
10.1038/nprot.2016.034 · 2021 · External reference
Hypoxia-activated PEGylated paclitaxel prodrug nanoparticles for potentiated chemotherapy
10.1021/acsnano.2c05341 · 2022 · External reference
Iridium photosensitizer-constructed liposomes with a hypoxia-activated prodrug for destruction of hepatocellular carcinoma
10.1016/j.cclet.2022.07.009 · 2022 · External reference
Selective thrombosis of tumor for enhanced hypoxia-activated prodrug therapy
10.1002/adma.202104504 · 2021 · External reference
Self-immolative cationic Iridium(III) complex-encapsulated nanoprodrug for enhanced chemo-photodynamic synergistic therapy of Melanomas
10.1021/jacs.5c06657 · 2025 · External reference
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges
10.1038/s41573-023-00848-6 · 2024 · External reference
Activatable fluorescence and bio/chemiluminescence probes for aminopeptidases: from design to biomedical applications
10.1002/adma.202409893 · 2024 · External reference
As chemiluminescence meets aggregation-induced near-infrared emission: opening a wonderland for advanced fluorescence imaging
10.1016/j.ccr.2025.217285 · 2026 · External reference
Recent advances in glow-type chemiluminescence: systems, strategies and analytical applications
10.1016/j.trac.2025.118393 · 2025 · External reference
Near-infrared chemiluminescent theranostics
10.1002/anie.202501681 · 2025 · External reference
Chemiluminescent probes in cancer biology
10.1038/s44222-023-00074-0 · 2023 · External reference
Bioorthogonally activatable chemiluminescence for the N-Methyl-d-aspartate receptors intravital imaging
10.1002/anie.202523648 · 2026 · External reference
Chemiluminescence resonance energy transfer for targeted photoactivation of ion channels in living cells
10.1002/anie.202423792 · 2025 · External reference
Size-transformable superoxide-triggered nanoreporters for crosstalk-free dual fluorescence/chemiluminescence imaging and urinalysis in living mice
10.1002/anie.202305812 · 2023 · External reference
Unprecedented photoinduced-electron-transfer probe with a Turn-ON chemiluminescence mode-of-action
2024 · External reference
Hydrogen sulfide donor featuring dual-modal imaging for the theranostic management of drug-induced liver injury
10.1021/acs.jmedchem.5c03427 · 2026 · External reference
Phosphorylated chemiluminescent probe based on spiro-cyclobutyl-phenoxy-dioxetane for the in situ light-activated sensing of alkaline phosphatase
10.1021/acs.analchem.5c07061 · 2026 · External reference
Ultrasound-triggered type I supramolecular photosensitizer for precise in situ chemiluminescence-based photodynamic cyclic therapy
10.1021/jacs.5c15389 · 2026 · External reference
π-Bridge-Engineered near-infrared Schaap's chemiluminescent probes for precise tumor diagnosis and imaging-guided surgery
10.1021/jacs.6c03574 · 2026 · External reference
Direct real-time monitoring of prodrug activation by chemiluminescence
10.1002/anie.201804816 · 2018 · External reference
A nitroreductase-activated chemiluminescent prodrug for real-time monitoring of camptothecin release in peritoneal metastasis theranostics
10.1021/acs.jmedchem.5c01674 · 2025 · External reference
An Azoreductase-Activated self-monitoring prodrug for chemiluminescence imaging and safe chemotherapy breast cancer
10.1021/acs.jmedchem.5c02922 · 2026 · External reference
Recent advances in strategies to enhance photodynamic and photothermal therapy performance of single-component organic phototherapeutic agents
10.1002/advs.202409157 · 2025 · External reference
Design strategies for aggregation-induced emission photosensitizers with enhanced safety in photodynamic therapy
10.1016/j.ccr.2024.215756 · 2024 · External reference
Self-assembly strategies of organic small-molecule photosensitizers for photodynamic therapy
10.1016/j.ccr.2024.215863 · 2024 · External reference
Taking phototherapeutics from concept to clinical launch
10.1038/s41570-021-00326-w · 2021 · External reference
Bioorthogonal chemistry and illumination controlled programmed size-changeable nanomedicine for synergistic photodynamic and hypoxia-activated therapy
10.1016/j.biomaterials.2022.121480 · 2022 · External reference
Correction to tumor-penetrating nanoparticles for enhanced anticancer activity of combined photodynamic and hypoxia-activated therapy
10.1021/acsnano.9b01888 · 2019 · External reference
Engineering nanomedicine with oxidative stress amplification and antioxidant defense disruption for enhanced cancer treatment
10.1021/acs.jmedchem.5c01817 · 2025 · External reference
Enhancing the release efficiency of a molecular chemotherapeutic prodrug by photodynamic therapy
10.1002/anie.202206169 · 2022 · External reference
A hypoxia-activated BODIPY-Azo anticancer prodrug for bimodal chemo-photodynamic therapy
10.1021/acs.jmedchem.4c02231 · 2025 · External reference
Hypoxia-Responsive paclitaxel prodrugs: linker evaluation and NIR-triggered self-amplifying photodynamic-chemotherapy nanoplatform
10.1016/j.biomaterials.2026.124083 · 2026 · External reference
A light-activatable theranostic combination for ratiometric Hypoxia imaging and oxygen-deprived drug activity enhancement
10.1038/s41467-023-44429-y · 2024 · External reference
A light-controlled multi-step drug release nanosystem targeting tumor hypoxia for synergistic cancer therapy
10.1039/d1sc01888d · 2021 · External reference
Multifunctional theranostic liposomes loaded with a hypoxia-activated prodrug for cascade-activated tumor selective combination therapy
10.1021/acsami.9b11080 · 2019 · External reference
Pillar[5]arene based prodrug as a GSH-responsive SO2 nanogenerator for effective gas cancer therapy
10.1016/j.cclet.2024.110808 · 2025 · External reference
Recent developments in Pillar[5]arene-Based nanomaterials for cancer therapy
10.1039/d4cc05660d · 2025 · External reference
